SCHEMBL5740992

SCHEMBL5740992

O=C(NCc1ccc(C(F)(F)F)cc1)N1CCCCC1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 3/20 0.59
KCNH2 Q12809 1/20 0.59
MEN1 O00255 3/20 0.55
KMT2A Q03164 3/20 0.55
HPGD P15428 1/20 0.55
TSHR P16473 1/20 0.55
KDM4E B2RXH2 2/20 0.50
ALDH1A1 P00352 1/20 0.50
MTTP P55157 2/20 0.49
NAMPT P43490 1/20 0.49
FAAH O00519 1/20 0.48
MTOR P42345 1/20 0.48
MLLT1 Q03111 1/20 0.47
TEAD1 P28347 1/20 0.47
LSS P48449 1/20 0.47
HDAC3 O15379 1/20 0.47
HDAC1 Q13547 1/20 0.47
HDAC2 Q92769 1/20 0.47
HDAC10 Q969S8 1/20 0.47
HDAC11 Q96DB2 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21131047 0.86 NOS3 (0.58) HRH3KCNH2MEN1KMT2AHPGD
SCHEMBL5464853 0.86 MEN1 (0.70) HRH3KCNH2MEN1KMT2AKDM4E
SCHEMBL32660728 0.86 KCNH2 (0.51) HRH3KCNH2MEN1KMT2AKDM4E
SCHEMBL23252438 0.81 KMT2A (0.55) HRH3MEN1KMT2AKDM4EMLLT1
SCHEMBL32660745 0.80 MAPT (0.64) HRH3KCNH2MEN1KMT2A
SCHEMBL30677754 0.80 KMT2A (0.60) HRH3MEN1KMT2AHPGDALDH1A1
SCHEMBL6559744 0.80 KDM4E (0.68) HRH3MEN1KMT2ATSHRKDM4E
SCHEMBL5217325 0.80 KDM4E (0.68) HRH3MEN1KMT2ATSHRKDM4E
SCHEMBL4559263 0.78 TP53 (0.63) MEN1KMT2ATSHRALDH1A1
SCHEMBL3126965 0.78 NPC1 (0.57) HRH3MEN1KMT2AHPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1673059-A2 ALKANOL AND CYCLOALKANOL-AMINE DERIVATIVES AND METHODS OF THEIR USE Wyeth (US) 2006-06-28 EP disclosed
WO-2005037207-A2 ARYLALKYL-PIPERAZINE DERIVATIVES FOR THE TREATMENT OF CONDITIONS AMELIORATED BY MONOAMINE REUPTAKE INCLUDING VASOMOTOR SYMPTOMS (VMS) WYETH (US) 2005-04-28 WO disclosed